Our immunohistochemical studies revealed strong expression of FAM159B in tumours of endocrine or neuroendocrine origin, such as pituitary adenomas, BP-NEN and GEP-NEN, medullary and anaplastic thyroid carcinomas and parathyroid adenomas. Here, SHISAL2B is linked to parathyroid gland adenoma.